Why is Cellebrite stock surging today?
Cellebrite's stock rose 5.9% in pre-market trading after Q3 2026 results beat expectations, with non-GAAP EPS of $0.17 vs. $0.10 consensus. Annual recurring revenue grew 20% YoY to $528.5M. The company raised its 2026 adjusted EBITDA outlook to $163M-$166M. CEO Shiv Ramji cited strong international and U.S. Federal performance. Operating cash flow increased 70% to $56.58M.
How this was made
The 30-second read
Why it matters
The earnings surprise and guidance raise provide a fresh catalyst for traders, suggesting a near‑term buying opportunity.
Market read
Earnings beat and guidance lift drive a notable pre‑market rally, offering a clear trade signal.
What to watch
Potential headwinds from slower federal procurement cycles or competitive pressure from larger security vendors.
Background
Cellebrite's Q3 results beat expectations and include a 20% YoY ARR increase, prompting a pre‑market price jump.
Ticker impact
Cellebrite reported a Q3 EPS beat of $0.17 vs $0.10 consensus and raised its 2026 adjusted EBITDA guidance, driving a 5.9% pre‑market surge.
upward pressure as the market absorbs the earnings beat and higher EBITDA outlook
Fresh, material earnings data with a double‑digit ARR increase and guidance lift, combined with a near‑6% pre‑market move, constitute a clear, time‑sensitive catalyst.
Market effects
Strong earnings may boost sentiment in the digital forensics and security software sector.
U.S. tech stocks could see modest upside despite broader market weakness.
Limited; impact is primarily confined to U.S. listed tech equities.
Counterpoint
If the broader market continues to decline, the rally could be short‑lived and the stock may face profit‑taking.
Key entities
- companyCellebrite
Provider of digital intelligence solutions, ticker CLBT.
- executiveShiv Ramji
CEO of Cellebrite who highlighted the earnings beat and guidance raise.
